LWWOnline  |  LOGIN  |  eALERTS  |  REGISTER  |  CUSTOMER SUPPORT   |  NIH PUBLIC ACCESS POLICY  
banner
Home Search Current Issue Archive Publish Ahead of Print

June 2008, 35:6 > Seroprevalence of Herpes Simplex...
< Previous  |   Next >
ARTICLE LINKS:
Fulltext  |  PDF (299 K)
Seroprevalence of Herpes Simplex Virus Type 2 and Characteristics Associated With Undiagnosed Infection: New York City, 2004.

Article

Sexually Transmitted Diseases. 35(6):599-606, June 2008.
Schillinger, Julia A. MD, MSc *+; McKinney, Christy M. PhD, MPH ++; Garg, Renu MPH *; Gwynn, R Charon PhD [S]; White, Kellee MPH [//]; Lee, Francis MD, MSc [P]; Blank, Susan MD *+; Thorpe, Lorna PhD *; Frieden, Thomas MD *

Abstract:
Background: Herpes simplex virus type 2 (HSV-2) infection is associated with substantial morbidity and increased risk for human immunodeficiency virus acquisition. We describe HSV-2 seroprevalence in adult New Yorkers, and examine the relationship between select characteristics, infection, and diagnosis.

Methods: HSV-2 seroprevalence and risk factors were measured using the 2004 New York City Health and Nutrition Examination Survey, a population-based cross-sectional survey of adults. HSV-2 seroprevalence and corresponding 95% confidence intervals were computed for select characteristics. Associations between proposed risk factors and HSV-2 infection and diagnosis were estimated using unadjusted and adjusted odds ratios.

Results: Nearly 28% of adults were infected with HSV-2; 88.4% of HSV-2 positive persons were undiagnosed. Black women had the highest seroprevalence (59.7%) of any sex or race/ethnicity group. Women, non-Hispanic blacks, and Hispanics (vs. non-Hispanic whites), and men who have sex with men were at greater odds of HSV-2 infection. Among HSV-2 infected individuals, non-Hispanic blacks (vs. non-Hispanic whites), uncircumcised men, and those with no routine place of care were less likely to be diagnosed.

Conclusions: HSV-2 is highly prevalent and largely undiagnosed in New York City; seroprevalence varies by subgroup. Targeted HSV-2 screening, counseling and treatment may help reduce transmission of HSV-2 and human immunodeficiency virus.

(C) Copyright 2008 American Sexually Transmitted Diseases Association


Copyright © 2008, American Sexually Transmitted Diseases Association. All rights reserved.
Published by Lippincott Williams & Wilkins.
Copyright/Disclaimer NoticePrivacy Policy
rssicon Subscribe to our RSS feed
txrdc-pt02.tx.ovid.com
Release 4.7.0